Quadrature Capital’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-75,889
Closed -$15.6M 1226
2022
Q4
$15.6M Sell
75,889
-2,839
-4% -$718K 0.46% 50
2022
Q3
$21.9M Buy
+78,728
New +$20M 0.71% 34
2022
Q1
Sell
-6,120
Closed -$1.09M 1022
2021
Q4
$1.09M Buy
6,120
+4,579
+297% +$903K 0.06% 215
2021
Q3
$317K Buy
+1,541
New +$303K 0.01% 492
2021
Q2
Sell
-3,100
Closed -$404K 1284
2021
Q1
$404K Buy
+3,100
New +$372K 0.02% 536
2020
Q4
Sell
-10,310
Closed -$782K 1116
2020
Q3
$782K Buy
+10,310
New +$585K 0.05% 399

Other funds holding SWAV

Quadrature Capital's SWAV Position: Q1 2023 in Review

Quadrature Capital sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2023, closing a stake of 75,889 shares — an estimated $15.6M sold.

Quadrature Capital first reported a position in SWAV in Q3 2020 and held it in 6 quarters. The position peaked at $21.9M in Q3 2022. 381 funds tracked by Wall St. Rank hold SWAV as of Q1 2023.

  • Quadrature Capital reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Quadrature Capital sold 75,889 Shockwave Medical, Inc. Common Stock shares in Q1 2023, an estimated $15.6M.
  • Quadrature Capital first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
  • Quadrature Capital's Shockwave Medical, Inc. Common Stock position peaked at $21.9M in Q3 2022.
  • 381 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2023.

Based on Quadrature Capital's 13F filing for Q1 2023, filed 15 May 2023.